Atlas Trials

Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors

Clinical trial NCT07421518 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07421518
Sponsor
AdventHealth Translational Research Institute
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 DiabetesType 2 Diabetes
Start date
2026-06-01
Primary completion
2030-04-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.